Regulation 55 Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004

(1)

The Medicines for Human Use (Clinical Trials) Regulations 2004^f1 are amended as follows.

(2)

In regulation—

(a)

17(2)(b)(ii) (request for authorisation to conduct a clinical trial),

(b)

24(10) (amendments by the sponsor),

(c)

38(3)(b) (application for manufacturing authorisation),

(d)

44(8) (variation of manufacturing authorisation),

for “Medicines (Products for Human Use) (Fees) Regulations 2010” substitute “Medicines (Products for Human Use) (Fees) Regulations 2012”.

Annotations

f1: S.I. 2004/1031; relevant amendments are made by S.I. 2006/1928, 2010/551.